Stay updated on AT2220 Safety Study in Pompe Disease Clinical Trial

Sign up to get notified when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AT2220 Safety Study in Pompe Disease Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with Georgia listed as a site. Also removed the HHS Vulnerability Disclosure and Georgia Locations entries, and updated the revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T20:41:06.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2 instead of Revision: v3.2.0. This reflects a site update/versioning detail.
    Difference
    0.1%
    Check dated 2025-11-24T21:55:49.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The notice about government funding operating status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T20:03:55.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The changes appear limited to administrative updates (e.g., last update date) with no modifications to core study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:51:02.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Major update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T04:27:24.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Updated canonical name to Glycogen storage disease II and bumped revision to v3.1.0, replacing the prior Glycogen storage disease ii and v3.0.2.
    Difference
    0.2%
    Check dated 2025-09-29T00:58:08.000Z thumbnail image

Stay in the know with updates to AT2220 Safety Study in Pompe Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.